BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 25198125)

  • 1. Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.
    Cheraï M; Hamel Y; Baillou C; Touil S; Guillot-Delost M; Charlotte F; Kossir L; Simonin G; Maury S; Cohen JL; Lemoine FM
    Cell Transplant; 2015; 24(12):2527-40. PubMed ID: 25198125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation.
    Lim DG; Koo SK; Park YH; Kim Y; Kim HM; Park CS; Kim SC; Han DJ
    Transplantation; 2010 Apr; 89(8):928-36. PubMed ID: 20305583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
    Yamazaki S; Inaba K; Tarbell KV; Steinman RM
    Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.
    Putnam AL; Safinia N; Medvec A; Laszkowska M; Wray M; Mintz MA; Trotta E; Szot GL; Liu W; Lares A; Lee K; Laing A; Lechler RI; Riley JL; Bluestone JA; Lombardi G; Tang Q
    Am J Transplant; 2013 Nov; 13(11):3010-20. PubMed ID: 24102808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys.
    Ma A; Qi S; Song L; Hu Y; Dun H; Massicotte E; Dupuis M; Daloze P; Chen H
    Int Immunopharmacol; 2011 May; 11(5):618-29. PubMed ID: 21094689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
    Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
    Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction.
    Yamazaki S; Patel M; Harper A; Bonito A; Fukuyama H; Pack M; Tarbell KV; Talmor M; Ravetch JV; Inaba K; Steinman RM
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2758-63. PubMed ID: 16473944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantigen specific T regulatory cells in transplant tolerance.
    Hall BM; Tran G; Hodgkinson SJ
    Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic Mature Human Dendritic Cells Generate Superior Alloreactive Regulatory T Cells in the Presence of IL-15.
    Litjens NH; Boer K; Zuijderwijk JM; Klepper M; Peeters AM; Prens EP; Verschoor W; Kraaijeveld R; Ozgur Z; van den Hout-van Vroonhoven MC; van IJcken WF; Baan CC; Betjes MG
    J Immunol; 2015 Jun; 194(11):5282-93. PubMed ID: 25917092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.
    Pozo D; Anderson P; Gonzalez-Rey E
    J Immunol; 2009 Oct; 183(7):4346-59. PubMed ID: 19734220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro expanded alloantigen-specific CD4+CD25+ regulatory T cell treatment for the induction of donor-specific transplantation tolerance.
    Jiang S; Golshayan D; Tsang J; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1879-82. PubMed ID: 17161340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subset of CD8+ T cells acquiring selective suppressive properties may play a role in GvHD management.
    Avivi I; Stroopinsky D; Rowe JM; Katz T
    Transpl Immunol; 2013 Jan; 28(1):57-61. PubMed ID: 23196257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D-modulated dendritic cells delay lethal graft-versus-host disease through induction of regulatory T cells.
    Vanherwegen AS; Cook DP; Ferreira GB; Gysemans C; Mathieu C
    J Steroid Biochem Mol Biol; 2019 Apr; 188():103-110. PubMed ID: 30605776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloantigen-specific CD4(+) regulatory T cells induced in vivo by ultraviolet irradiation after alloantigen immunization require interleukin-10 for their induction and activation, and flexibly mediate bystander immunosuppression of allograft rejection.
    Hori T; Kuribayashi K; Saito K; Wang L; Torii M; Uemoto S; Kato T
    Transpl Immunol; 2015 Jun; 32(3):156-63. PubMed ID: 25861842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
    Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.